Eli Lilly's Retatrutide Shows Dramatic Weight Loss in Trials
· via Ars Technica
Original source
Most powerful obesity drug yet: People lost up to 25% of weight in trial
Ars Technica →Eli Lilly’s new obesity drug, retatrutide, combines three hormones—GLP-1, GIP, and glucagon—to regulate blood sugar, appetite, and metabolism. Early trials show significant weight loss, up to 25% of body weight, building on the success of previous dual-hormone drugs like tirzepatide. The drug targets multiple metabolic pathways, offering a more comprehensive approach to obesity treatment.
Read the full article
Continue reading at Ars Technica →This is an AI-generated summary. Read the original for the full story.